1410P Safety and efficacy of vibostolimab, an anti-TIGIT...

Annals of Oncology 2020 / 09 Vol. 31

1410P Safety and efficacy of vibostolimab, an anti-TIGIT antibody, plus pembrolizumab in patients with anti-PD-1/PD-L1-naive NSCLC

Niu, J., Nagrial, A., Voskoboynik, M., Chung, H.C., Lee, D.H., Ahn, M-J., Bauer, T.M., Jimeno, A., Chung, V., Mileham, K.F., Chartash, E., Chen, D., Healy, J., Rajasagi, M., Maurice-Dror, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.1724
Date:
September, 2020
File:
PDF, 129 KB
2020
Conversion to is in progress
Conversion to is failed